Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Cardiac Toxicity
Interventions: DRUG: Coreg CR®|DRUG: lisinopril|OTHER: placebo
Sponsor: University of South Florida
Collaborators: National Cancer Institute (NCI)